Plain-English translation of NCT04172753 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new hybrid machine called an MR-Linac that combines MRI imaging with radiation therapy in one device. The goal is to see if using this advanced machine can deliver more precise cancer treatment by letting doctors see the tumor better and adjust the treatment plan each day before therapy.
Standard radiation therapy uses older imaging technology that doesn't show soft tissue as clearly. This new treatment could improve how accurately radiation is aimed at tumors while sparing nearby healthy tissue, potentially leading to better outcomes and fewer side effects.
You likely qualify if…
You likely don't qualify if…
Depending on your cancer type, you would receive radiation therapy sessions using the new MR-Linac machine. Before each treatment, doctors would take MRI images to see your tumor, and may adjust your treatment plan based on what they see that day. The study is testing whether this approach is safe and practical across different cancer types.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Germany
Sponsor
University Hospital Tuebingen
Enrollment target
~472 participants
Started
May 2018
Primary completion
May 2022
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in November 2019.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.